Document 2403
 DOCN  M94A2403
 TI    Hospitalization and medical care pattern of HIV positive women in
       Montreal.
 DT    9412
 AU    Osborne ME; Ghadirian P; Poisson M; Morisset R; Beaulieu R; Microbiology
       Department, Hospital Hotel-Dieu de Montreal,; Canada.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):312 (abstract no. PC0177). Unique
       Identifier : AIDSLINE ICA10/94370172
 AB    OBJECTIVE: To assess the pattern of given medical care to seropositive
       women in Montreal, taking into account their survival rate. METHOD: A
       total of 76 medical records of seropositive women out of 768 medical
       records of hospitalized HIV positive and AIDS patients (female and male)
       at Hotel-Dieu de Montreal during 1984-1993 were revised. RESULTS: Of 76
       medical records studied, 50% were French Canadians (FC), 45% Haitians
       (H) and 5% others. The mean age for H group was 38.8 yr, for FC 37.7 and
       for others 32.5 yrs. The overall risk factors (RF) 65% were
       heterosexuals (HR) (53% H, 45% FC and 2% other); all 20% of I.V.D.U.
       were FC, 3% were infected by bl. transfusion, while 12% indicated no
       known RF. Only 1% were infected by the needle stick injury. The overall
       CDC IV stage disease in H patients was found in 15 (44.1%), CDC III in 9
       (26.4%) and CDC II in 10 (29.4%). Among FC the overall CDC staging of
       the disease were 13 (34.2%), 17 (44.7%) and 19 (50%) for stage IV, III
       and II retrospectively. Of 34 H patients the prevalence of Oral Candida
       (OC) was 38.2%, PCP 35.2%, CMV 26.4%, toxoplasmosis 14.7% and the rest
       was T.B., Cryptosporidiosis, K.S. and lymphoma. This rates for 38 FC
       were 44.7% for O.C., 34.2% for P.C.P., 10.5% for CMV, 7.8% for
       toxoplasmosis and the rest were T.B., Cryptosporidiosis and lymphoma.
       Overall prevalence for antiretroviral treatment was 47.3%, for PCP
       prophylaxis was 40.7% and other prophylaxis 60.5%. CONCLUSION: The major
       RF for HIV sero+ women living in Montreal is HR behaviour. Higher
       survival rates were observed in H women. Women receiving combined
       prophylaxis seam to have higher survival rates. Around 59% of H patients
       had a survival period of 41.3 months after the HIV diagnosis, as
       compared with 47% of FC with a survival period of 34.9 months,
       indicating shorter survival period for FC women.
 DE    Adult  AIDS-Related Opportunistic Infections/DRUG THERAPY  Female
       Hospitalization/*STATISTICS & NUMER DATA  Human  HIV
       Infections/MORTALITY/*THERAPY/TRANSMISSION  HIV Seropositivity  Male
       Quebec/EPIDEMIOLOGY  Risk Factors  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).